215 related articles for article (PubMed ID: 18068106)
1. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection.
Hayashi K; Nakano T; Hashimoto M; Kanekiyo K; Hayashi T
Int Immunopharmacol; 2008 Jan; 8(1):109-16. PubMed ID: 18068106
[TBL] [Abstract][Full Text] [Related]
2. Anti-influenza A virus characteristics of a fucoidan from sporophyll of Undaria pinnatifida in mice with normal and compromised immunity.
Hayashi K; Lee JB; Nakano T; Hayashi T
Microbes Infect; 2013 Apr; 15(4):302-9. PubMed ID: 23376164
[TBL] [Abstract][Full Text] [Related]
3. Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu).
Lee JB; Hayashi K; Hashimoto M; Nakano T; Hayashi T
Chem Pharm Bull (Tokyo); 2004 Sep; 52(9):1091-4. PubMed ID: 15340195
[TBL] [Abstract][Full Text] [Related]
4. Mekabu fucoidan: structural complexity and defensive effects against avian influenza A viruses.
Synytsya A; Bleha R; Synytsya A; Pohl R; Hayashi K; Yoshinaga K; Nakano T; Hayashi T
Carbohydr Polym; 2014 Oct; 111():633-44. PubMed ID: 25037398
[TBL] [Abstract][Full Text] [Related]
5. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
6. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
7. The role of NK cells in antitumor activity of dietary fucoidan from Undaria pinnatifida sporophylls (Mekabu).
Maruyama H; Tamauchi H; Iizuka M; Nakano T
Planta Med; 2006 Dec; 72(15):1415-7. PubMed ID: 17054048
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of Undaria pinnatifida against herpes simplex virus.
Thompson KD; Dragar C
Phytother Res; 2004 Jul; 18(7):551-5. PubMed ID: 15305315
[TBL] [Abstract][Full Text] [Related]
9. Naloxone, an opioid receptor antagonist, enhances induction of protective immunity against HSV-1 infection in BALB/c mice.
Jamali A; Mahdavi M; Shahabi S; Hassan ZM; Sabahi F; Javan M; Farsani MJ; Parsania M; Bamdad T
Microb Pathog; 2007; 43(5-6):217-23. PubMed ID: 17669616
[TBL] [Abstract][Full Text] [Related]
10. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
11. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
Mitchell BM; Stevens JG
J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
[TBL] [Abstract][Full Text] [Related]
12. Growth-inhibitory effect of a fucoidan from brown seaweed Undaria pinnatifida on Plasmodium parasites.
Chen JH; Lim JD; Sohn EH; Choi YS; Han ET
Parasitol Res; 2009 Jan; 104(2):245-50. PubMed ID: 18791738
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
14. Activity of the Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice: role of peritoneal macrophage activation.
Ikeda S; Nishiya S; Yamamoto A; Yamase T; Nishimura C; De Clercq E
J Med Virol; 1993 Nov; 41(3):191-5. PubMed ID: 8263499
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice.
El-Ghorr AA; Williams RM; Heap C; Norval M
FEMS Immunol Med Microbiol; 2000 Dec; 29(4):255-61. PubMed ID: 11118905
[TBL] [Abstract][Full Text] [Related]
16. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
18. In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.
Cardozo FT; Larsen IV; Carballo EV; Jose G; Stern RA; Brummel RC; Camelini CM; Rossi MJ; Simões CM; Brandt CR
Antimicrob Agents Chemother; 2013 Jun; 57(6):2541-9. PubMed ID: 23507287
[TBL] [Abstract][Full Text] [Related]
19. Acute morphine administration reduces cell-mediated immunity and induces reactivation of latent herpes simplex virus type 1 in BALB/c mice.
Mojadadi S; Jamali A; Khansarinejad B; Soleimanjahi H; Bamdad T
Cell Mol Immunol; 2009 Apr; 6(2):111-6. PubMed ID: 19403060
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of T helper type 1 immune response through intestinal immunity in murine cutaneous herpes simplex virus type 1 infection by probiotic Lactobacillus plantarum strain 06CC2.
Matsusaki T; Takeda S; Takeshita M; Arima Y; Tsend-Ayush C; Oyunsuren T; Sugita C; Yoshida H; Watanabe W; Kurokawa M
Int Immunopharmacol; 2016 Oct; 39():320-327. PubMed ID: 27517518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
